96-well format targeted proteomics platform for biomarker detection with high sensitivity and specificity. Delivers results in under 2 hours and supports multiple sample types including blood, plasma, saliva, and milk without reconfiguration.
Manufactured by
United States
Pictor® is a decision-grade targeted proteomics platform that enables partners to turn the right small set of proteins into deployable, scalable tests. Built for deployment rather than discovery, Pictor combines a customizable assay platform (PictArray®), dedicated imaging (PictImager®), and automated analysis software (Pictorial®) into a streamlined workflow designed to improve productivity, turnaround time, and cost for diagnostic, life science, and animal health partners. The company operates a partner-first, capital-efficient revenue model: partners fund assay development upfront, while Pictor earns high-margin recurring revenue from consumables and per-test economics as assays move into routine use. To date, Pictor has signed and advanced multiple partner programs, moved assays into real laboratory workflows, and demonstrated repeatable expansion within partners—validating both the technical platform and the scalability of its partner-driven business model.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Xenta Biomedical Science Co.,Ltd
China · 1 relevant product
Salignostics LTD
Israel · 1 relevant product
Shenzhen YHLO Biotech Co., Ltd.
China · 2 relevant products
Response Biomedical
Canada · 1 relevant product
Excélsior Bio-System Incorporation
Taiwan · 1 relevant product
tst biomedical electronics Co., Ltd.
Taiwan · 1 relevant product
Siemens Healthineers
United States · 1 relevant product
S&T BioMed CO., LTD.
Taiwan · 1 relevant product
BIOTYPE GmbH
Germany · 1 relevant product
Biomerica, Inc.
United States · 1 relevant product
35 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 50 closest product alternatives
Xenta Biomedical Science Co.,Ltd · China
An innovative molecular detection platform utilizing microfluidic PCR technology capable of completing nucleic acid rapid detection within 30 minutes with high sensitivity and high specificity. The reagents are stable at room temperature without requiring cold chain storage, support customized multiplex detection, and can simultaneously detect up to 48 targets, providing an efficient solution for multi-pathogen detection.
Salignostics LTD · Israel
A comprehensive diagnostic platform utilizing saliva biomarkers for disease detection, designed for both home use and point-of-care settings. The platform combines sample collection, processing, and analysis in a user-friendly format.
Shenzhen YHLO Biotech Co., Ltd. · China
An integrated biochemistry testing platform for clinical laboratory diagnostics. The system encompasses multiple biochemical assays approved for clinical use in patient sample analysis.
Response Biomedical · Canada
Integrated point of care testing platform designed for rapid diagnostic analysis in clinical environments, supporting multiple biomarker assays for immediate patient assessment and decision-making.
Excélsior Bio-System Incorporation · Taiwan
Proprietary microarray technology platform for immunological testing and allergen detection. Enables high-throughput analysis of biological markers in clinical diagnostics.
tst biomedical electronics Co., Ltd. · Taiwan
A next-generation diagnostic platform using high-frequency SH-SAW sensor technology to detect biomarkers for heart disease, inflammation, and cancer. The platform processes 5 μL of whole blood without red blood cell interference and delivers results in under 3 minutes.
Siemens Healthineers · United States
Integrated platform for advanced biomarker analysis supporting early disease detection, risk stratification, and prognostic assessment across cardiometabolic, liver, cardiovascular, and brain health conditions.
S&T BioMed CO., LTD. · Taiwan
Automated immunoassay system utilizing electrochemical detection methods for biomarker quantification. Suitable for high-throughput clinical laboratory applications.
BIOTYPE GmbH · Germany
A proprietary platform enabling comprehensive multi-biomarker testing in one integrated workflow. Designed for robust molecular precision diagnostics in oncology and clinical research.
Biomerica, Inc. · United States
A point-of-care diagnostic platform supporting manual to high-throughput ELISA testing with easy automation capabilities. Enables laboratory-accurate results at the point-of-care.
GENSPEED Biotech GmbH · Austria
Point-of-care platform enabling simultaneous quantification of up to 8 biomarkers from 20-50 µl of capillary blood in 15 minutes. CE-IVD and IVDR certified technology designed for OEM integration and personalized medicine applications.
Guangzhou Wondfo Biotech Co., Ltd. · China
Molecular diagnostics platform for nucleic acid detection and amplification-based testing. Enables identification of pathogens and genetic markers for infectious disease and other molecular-based diagnoses.
38 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products